{"log_id": 3935952258435049978, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.01847, "average": 0.912247, "min": 0.495426}, "location": {"width": 1298, "top": 73, "height": 224, "left": 251}, "words": "细胞外液成分,并根据需要调节成分。目前在置换液所用的碱基成分常为乳、盐、"}, {"probability": {"variance": 0.032853, "average": 0.720228, "min": 0.523017}, "location": {"width": 283, "top": 84, "height": 41, "left": 1193}, "words": "说红书穿"}, {"probability": {"variance": 0, "average": 0.954112, "min": 0.954112}, "location": {"width": 34, "top": 89, "height": 32, "left": 1534}, "words": "页"}, {"probability": {"variance": 0.024561, "average": 0.836678, "min": 0.61091}, "location": {"width": 59, "top": 180, "height": 32, "left": 235}, "words": "2036"}, {"probability": {"variance": 0.032217, "average": 0.902024, "min": 0.500963}, "location": {"width": 91, "top": 162, "height": 41, "left": 354}, "words": "0548.8"}, {"probability": {"variance": 0.033703, "average": 0.867812, "min": 0.406899}, "location": {"width": 1248, "top": 198, "height": 155, "left": 256}, "words": "酸盐和碳酸慧,其中的乳酸盐和醋酸盐均需经历脏代谢为磷酸(盐因此对MOD8"}, {"probability": {"variance": 0.021411, "average": 0.91263, "min": 0.427545}, "location": {"width": 1220, "top": 272, "height": 144, "left": 260}, "words": "政血症伴乳酸酸中或合并肝功能障碍者显然是不宜引使用乳酸盐手普变盐成分"}, {"probability": {"variance": 0.021565, "average": 0.930198, "min": 0.403593}, "location": {"width": 1024, "top": 333, "height": 134, "left": 267}, "words": "的。比外,现有的研究还表明,大量入醋酸盐也会引起血流动力学不稳定"}, {"probability": {"variance": 0.020347, "average": 0.919632, "min": 0.360706}, "location": {"width": 1150, "top": 388, "height": 139, "left": 331}, "words": "由于目前使用的各种置换液中均无含磷组分,而在临床进行连续性血液化治疗"}, {"probability": {"variance": 0.016809, "average": 0.935481, "min": 0.545662}, "location": {"width": 1211, "top": 448, "height": 139, "left": 269}, "words": "过程中对患老的血液电解质分析结果显示,其血磷浓废在连续性的血液净化过程中不"}, {"probability": {"variance": 0.014876, "average": 0.936196, "min": 0.515713}, "location": {"width": 1184, "top": 507, "height": 141, "left": 274}, "words": "断下降至出现低血磷症状。基于人体自身对血磷和血钙相互接抗平衡的调节机制:"}, {"probability": {"variance": 0.012633, "average": 0.960235, "min": 0.385413}, "location": {"width": 1207, "top": 567, "height": 146, "left": 274}, "words": "在低血磷出现的时候通常会伴随血钙的升高对息者的治疗和恢复是极为不利的为"}, {"probability": {"variance": 0.033275, "average": 0.897336, "min": 0.351889}, "location": {"width": 1200, "top": 626, "height": 141, "left": 281}, "words": "此,临床上在进行血液净化治疗后通常都需用聚糖二磷酸钠、磷酸甘油、磷酸萄"}, {"probability": {"variance": 0.019145, "average": 0.932145, "min": 0.382201}, "location": {"width": 1198, "top": 683, "height": 146, "left": 283}, "words": "糖等注射液子行补充血:白于患者全身的细胞外液在血液净化治疗过程中己几乎被"}, {"probability": {"variance": 0.026891, "average": 0.912441, "min": 0.386458}, "location": {"width": 1193, "top": 745, "height": 144, "left": 288}, "words": "完全置换,因此需要补磁的非常大而且为降低高实钙出现的问题,还应尽快实现"}, {"probability": {"variance": 0.018975, "average": 0.931684, "min": 0.499132}, "location": {"width": 1179, "top": 802, "height": 144, "left": 292}, "words": "对低血磷的纠偏治疗。但这含瞬制剂进入人体后由于询需通过在体内的水解方可产"}, {"probability": {"variance": 0.019899, "average": 0.911262, "min": 0.552279}, "location": {"width": 1177, "top": 861, "height": 141, "left": 299}, "words": "生游离的磷胶类成分,因此对低血磷纠偏治疗途度较慢,效果不甚理想。此外,这些"}, {"probability": {"variance": 0.028274, "average": 0.914801, "min": 0.418012}, "location": {"width": 823, "top": 944, "height": 121, "left": 297}, "words": "物尚有其他药作用,不可避免会产生或多或少的副作用"}, {"probability": {"variance": 0.020508, "average": 0.913381, "min": 0.490059}, "location": {"width": 1115, "top": 983, "height": 134, "left": 361}, "words": "除此以外,连接性血液净化治疗时可使患考每天去失750~000kca的热量,因此"}, {"probability": {"variance": 0.020713, "average": 0.930506, "min": 0.419788}, "location": {"width": 1166, "top": 1042, "height": 141, "left": 306}, "words": "必须在体液平衡的同时提供静脉营养。但前已有报道的血液量换液的成分是由各"}, {"probability": {"variance": 0.029955, "average": 0.915952, "min": 0.352643}, "location": {"width": 1131, "top": 1102, "height": 137, "left": 310}, "words": "种离子成的,一般常不含有萄糖,即使临时配制加入,糖的含一般也较高"}, {"probability": {"variance": 0.001315, "average": 0.976289, "min": 0.877204}, "location": {"width": 377, "top": 1218, "height": 82, "left": 315}, "words": "显然不利于体液中的糖平衡"}, {"probability": {"variance": 0.013968, "average": 0.935259, "min": 0.46085}, "location": {"width": 1097, "top": 1289, "height": 137, "left": 379}, "words": "鉴于此,本发明将提供一用于血液净化治疗的血液置换基础液,便其能更好地"}, {"probability": {"variance": 0.003459, "average": 0.937667, "min": 0.858802}, "location": {"width": 125, "top": 1314, "height": 48, "left": 320}, "words": "发阴容"}, {"probability": {"variance": 0.010128, "average": 0.95573, "min": 0.499446}, "location": {"width": 1147, "top": 1351, "height": 141, "left": 322}, "words": "适应临床使用需要,并能保证其质的稳定和无污染,又便于长期储存、运输,以"}, {"probability": {"variance": 0.027589, "average": 0.911255, "min": 0.440697}, "location": {"width": 791, "top": 1428, "height": 123, "left": 329}, "words": "决在用于血液净化治疗的血液置换液中行前存在钓上述问题"}, {"probability": {"variance": 0.019983, "average": 0.942591, "min": 0.483648}, "location": {"width": 1085, "top": 1470, "height": 137, "left": 388}, "words": "本发明所说的用于血液净化治疗的血液置换础液,在含有人体正常生理允许量"}, {"probability": {"variance": 0.02313, "average": 0.930208, "min": 0.356213}, "location": {"width": 1138, "top": 1529, "height": 141, "left": 333}, "words": "范围的钠、钙、镤、氯离子等成分的基础上,还含有萄糖,并可以含有离子成分"}, {"probability": {"variance": 0.009429, "average": 0.940838, "min": 0.639597}, "location": {"width": 827, "top": 1607, "height": 123, "left": 338}, "words": "和能产生游离磷酸类物质的成分,其中以豪摩尔/汗的含量为"}, {"probability": {"variance": 0.008458, "average": 0.949203, "min": 0.619465}, "location": {"width": 1001, "top": 1641, "height": 144, "left": 397}, "words": "葡萄糖2-30,钾离子成分0-7.0,能产生游离磷酸关物质的成分0-5.0"}, {"probability": {"variance": 0.01204, "average": 0.933691, "min": 0.570797}, "location": {"width": 1131, "top": 1707, "height": 141, "left": 345}, "words": "其中所说的能产生游离磷酸类物质的成分,为磷酸CH3PO4),和或能在体内产生出"}, {"probability": {"variance": 0.019374, "average": 0.905115, "min": 0.43529}, "location": {"width": 1106, "top": 1769, "height": 141, "left": 349}, "words": "酸二氢根离子(H2PO4)、磷酸根离子(HO42)或磷酸离子(PO23-)等的成分"}, {"probability": {"variance": 0.005885, "average": 0.962384, "min": 0.582385}, "location": {"width": 1060, "top": 1824, "height": 139, "left": 411}, "words": "如上述,根据临床治疗情况,本发明上述月于血液化治疗的血液置换基础液中"}, {"probability": {"variance": 0.010563, "average": 0.969785, "min": 0.501569}, "location": {"width": 676, "top": 1913, "height": 112, "left": 379}, "words": "般至少应含有所说的能产生游离磷酸类物质的成分"}, {"probability": {"variance": 0.00424, "average": 0.969125, "min": 0.744269}, "location": {"width": 1058, "top": 1945, "height": 132, "left": 416}, "words": "在上述用于血液净化治疗的血液置换基础液,所说的葡萄的含量更好范围是"}], "language": 3}